BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 16236519)

  • 1. Mammalian cyclin-dependent kinases.
    Malumbres M; Barbacid M
    Trends Biochem Sci; 2005 Nov; 30(11):630-41. PubMed ID: 16236519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle and cancer: genetic analysis of the role of cyclin-dependent kinases.
    Barbacid M; Ortega S; Sotillo R; Odajima J; Martín A; Santamaría D; Dubus P; Malumbres M
    Cold Spring Harb Symp Quant Biol; 2005; 70():233-40. PubMed ID: 16869759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
    Roskoski R
    Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6.
    Malumbres M; Sotillo R; Santamaría D; Galán J; Cerezo A; Ortega S; Dubus P; Barbacid M
    Cell; 2004 Aug; 118(4):493-504. PubMed ID: 15315761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I; Polyak K; Iavarone A; Massagué J
    Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living with or without cyclins and cyclin-dependent kinases.
    Sherr CJ; Roberts JM
    Genes Dev; 2004 Nov; 18(22):2699-711. PubMed ID: 15545627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
    Braun K; Hölzl G; Soucek T; Geisen C; Möröy T; Hengstschläger M
    Oncogene; 1998 Oct; 17(17):2259-69. PubMed ID: 9811456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK activation by non-cyclin proteins.
    Nebreda AR
    Curr Opin Cell Biol; 2006 Apr; 18(2):192-8. PubMed ID: 16488127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal Models for Studying the In Vivo Functions of Cell Cycle CDKs.
    Risal S; Adhikari D; Liu K
    Methods Mol Biol; 2016; 1336():155-66. PubMed ID: 26231715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulators of G1 cyclin-dependent kinases and cancers.
    Lee MH; Yang HY
    Cancer Metastasis Rev; 2003 Dec; 22(4):435-49. PubMed ID: 12884917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
    Mateyak MK; Obaya AJ; Sedivy JM
    Mol Cell Biol; 1999 Jul; 19(7):4672-83. PubMed ID: 10373516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
    Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
    Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulating the onset of cell cycle withdrawal in differentiated erythroid cells with cyclin-dependent kinases and inhibitors.
    Matushansky I; Radparvar F; Skoultchi AI
    Blood; 2000 Oct; 96(8):2755-64. PubMed ID: 11023509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into cyclins, CDKs, and cell cycle control.
    Sánchez I; Dynlacht BD
    Semin Cell Dev Biol; 2005 Jun; 16(3):311-21. PubMed ID: 15840440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal patterns of gene expression of G1-S cyclins and cdks during the first and second mitotic cell cycles in mouse embryos.
    Moore GD; Ayabe T; Kopf GS; Schultz RM
    Mol Reprod Dev; 1996 Nov; 45(3):264-75. PubMed ID: 8916036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual regulation of cyclin D1 and cyclin-dependent kinases cdk2 and cdk4 during in vivo mitotic stimulation of olfactory neuron progenitors in adult mouse.
    Kastner A; Moyse E; Bauer S; Jourdan F; Brun G
    J Neurochem; 2000 Jun; 74(6):2343-9. PubMed ID: 10820194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.